| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.1 |